Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 44 min ago
PreprintCC BYmedRxiv

A generator-matrix model quantifies the limited contribution of measured biomarkers to human mortality acceleration

  1. 1Oita University

Abstract

Aging clocks and biomarkers are increasingly used as if they were the mechanism that drives mortality. But a mechanism, unlike a thermometer, must satisfy three conditions: it must account for the mortality signal, be causal, and be the layer that reverses when aging is reversed. Using public or provider-restricted de-identified data, we test all three. First (accounting), a Markov generator-matrix model with death as an absorbing state, fitted jointly to biomarkers and mortality in NHANES (n=23,512) and replicated in the Health and Retirement Study, assigns most of the Gompertz rise in mortality to a component latent to measured blood biomarkers (92.7%; 89.1% under a mean-field re-specification; 91.5% on replication). Second (causation), a positive-control-calibrated, two-platform cis-pQTL Mendelian-randomization design (UKB-PPP, deCODE) detects known causal proteins (LPA, IL6R) yet finds the measurable inflammatory, renal and growth-signalling markers null. Third (reversibility), at donor level reprogramming reverses a chronological clock (-9.7 and -22.4 yr), whereas a causality-enriched damage clock shows no detectable reversal while somatic identity is retained and moves only as pluripotency is approached. On these data the biomarkers meet none of the three conditions; aging measures appear to track mortality risk rather than its cause, a caution for their use as surrogate end-points.

Related

  1. Single-Particle STORM Imaging Quantifies Coating Heterogeneity Among Cell Membrane-Coated Nanoparticles
    J. Blauser-Wilson, A. Zareein, S. Puth +7
    bioRxivPreprintCC BY-NC-NDFull textSystems & synthetic biologybioRxiv
  2. 2C-RT Quantifies Genome-Wide DNA Replication Perturbationsand Redefines RIF1-CDC7 Regulation of Replication Timing
    B. Urien, P. Y. Kuwong, G. Giglio +5
    bioRxivPreprintCC BYFull textCell biologybioRxiv
  3. Single-cell profiling quantifies the dose gap between population-average and complete pY-STAT1/3 suppression by JAK inhibitors
    K. E. Zakrzewska, J. Walczak, K. Nienałtowski +6
    bioRxivPreprintCC BY-NC-NDFull textSystems & synthetic biologybioRxiv
  4. AI-driven digital twinning quantifies the trade-off between flood conveyance and riparian stability under climate extremes
    Jae hun Shin, Seung Hwan Go, Jong Hwa Park
    Scientific ReportsPeer-reviewedCC BYFull textEcologyDOAJ
  5. TileScope quantifies spatial gene expression relationships beyond colocalization
    N. Macha, M. Arrieta-Lobo, S. Lillo +4
    bioRxivPreprintCC BY-NCFull textBioinformatics & computational biologybioRxiv
BibTeX
@misc{tanigawa2026generatormatrix,
  title = {{A generator-matrix model quantifies the limited contribution of measured biomarkers to human mortality acceleration}},
  author = {M. Tanigawa and T. Iwaki},
  howpublished = {medRxiv},
  year = {2026},
  month = jul,
  doi = {10.64898/2026.07.05.26356402},
  url = {https://www.medrxiv.org/content/10.64898/2026.07.05.26356402v2},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - A generator-matrix model quantifies the limited contribution of measured biomarkers to human mortality acceleration
AU  - M. Tanigawa
AU  - T. Iwaki
PY  - 2026
DA  - 2026/07/05
PB  - medRxiv
DO  - 10.64898/2026.07.05.26356402
UR  - https://www.medrxiv.org/content/10.64898/2026.07.05.26356402v2
AB  - Aging clocks and biomarkers are increasingly used as if they were the mechanism that drives mortality. But a mechanism, unlike a thermometer, must satisfy three conditions: it must account for the mortality signal, be causal, and be the layer that reverses when aging is reversed. Using public or provider-restricted de-identified data, we test all three. First (accounting), a Markov generator-matrix model with death as an absorbing state, fitted jointly to biomarkers and mortality in NHANES (n=23,512) and replicated in the Health and Retirement Study, assigns most of the Gompertz rise in mortality to a component latent to measured blood biomarkers (92.7%; 89.1% under a mean-field re-specification; 91.5% on replication). Second (causation), a positive-control-calibrated, two-platform cis-pQTL Mendelian-randomization design (UKB-PPP, deCODE) detects known causal proteins (LPA, IL6R) yet finds the measurable inflammatory, renal and growth-signalling markers null. Third (reversibility), at donor level reprogramming reverses a chronological clock (-9.7 and -22.4 yr), whereas a causality-enriched damage clock shows no detectable reversal while somatic identity is retained and moves only as pluripotency is approached. On these data the biomarkers meet none of the three conditions; aging measures appear to track mortality risk rather than its cause, a caution for their use as surrogate end-points.
ER  -